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Abstract: The highly invasive nature of glioblastoma is one of the most significant problems 
regarding the treatment of this tumor. Diamond nanoparticles (ND), graphite nanoparticles (NG), 
and graphene oxide nanoplatelets (nGO) have been explored for their biomedical applications, 
especially for drug delivery. The objective of this research was to assess changes in the adhesion, 
migration, and invasiveness of two glioblastoma cell lines, U87 and U118, after ND, NG, and 
nGO treatment. All treatments affected the cell surface structure, adhesion-dependent EGFR/
AKT/mTOR, and β-catenin signaling pathways, decreasing the migration and invasiveness of 
both glioblastoma cell lines. The examined nanoparticles did not show strong toxicity but effec-
tively deregulated cell migration. ND was effectively taken up by cells, whereas nGO and NG 
strongly interacted with the cell surface. These results indicate that nanoparticles could be used 
in biomedical applications as a low toxicity active compound for glioblastoma treatment.
Keywords: diamond, graphene oxide, graphite, nanoparticles, glioblastoma, migration, 
invasiveness
Introduction
Glioblastoma is one of the most common malignant tumors of the central nervous 
system with an average life expectancy of only 6 months to 2 years.1 This prognosis 
results from high tumor malignancy, an invasive phenotype, and the absence of an 
effective therapy. The ability of glioblastoma cells to undergo migration and invasion 
allows them to infiltrate brain tissue, while rarely undergoing extracranial metastasis.2 
Glioblastoma infiltrates surrounding brain tissue and therefore cannot be fully removed 
by surgical resection.
Cell motility is a process based on the dynamic properties of the actin cytoskeleton. 
Glioblastoma cells have a complex actin cytoskeleton-related cell surface morphology 
with abundant membrane folds, microvilli, and filopodia, which play a role in its 
invasive phenotype.3 Cell migration begins with polymerization of actin filaments and 
extending lamellipodia and filopodia protrusions of the cell membrane.4 Protrusions are 
stabilized by focal adhesions and actin cytoskeleton in the form of stress fibers. Adhe-
sion of tumor cells to extracellular matrix and extracellular sensing plays an important 
role in cell motility.5,6 Migration of tumor cells is regulated by various signaling path-
ways, including the EGFR/AKT/mTOR and β-catenin signaling pathways.7 Activation 
of those signaling pathways is also important in promoting tumor development, 
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metastasis, and resistance to cancer therapies.8,9 Glioblastoma 
tumors commonly have mutations in PTEN, which are the 
most common genetic changes found in human cancers.10 
PTEN inhibits the AKT signaling pathway, thus glioblastoma 
cells that have mutations in PTEN show constant activation 
of EGFR/AKT/mTOR signaling pathway.11
Carbon nanoparticles have been explored for biomedical 
applications and are considered a possible choice as a low 
toxicity tumor therapy or drug delivery strategy. Diamond 
nanoparticles (ND), graphite nanoparticles (NG), and gra-
phene oxide nanoplatelets (nGO) are carbon allotropes that, 
although similar in size, have different physical properties. 
ND has carbon atoms in sp3 hybridization, whereas NG 
and nGO have carbon atoms in the sp2 hexagonal pattern. 
However, nGO has a unique thickness to surface area ratio, 
which distinguishes this material from both ND and NG. 
Carbon nanoparticles can bind to the plasma membrane, 
where they can interfere with surface proteins, including 
receptors, and become endocytosed.12–16 This suggests that 
carbon nanoparticles, although not directly toxic, can influ-
ence cell activity. Despite low toxicity, ND have been shown 
to inhibit the growth of new blood vessels, hence reducing 
the development of glioblastoma tumors,13,17,18 suggesting 
reduction of cell migration.
In the present study, we hypothesized that ND, NG, and 
nGO can change abilities of glioblastoma cells to adhere to 
extracellular matrix, decreasing migration and invasiveness. 
We investigated endocytosis of nanoparticles, cell ultrastruc-
ture, adhesion-dependent EGFR/AKT/mTOR, and β-catenin 
signaling of two glioblastoma cell lines, U87 and U118.
Materials and methods
Nanomaterials
ND and NG were purchased from SkySpring Nanomaterials 
(Houston, TX, USA). nGO were obtained from the Institute 
of Electronic Materials Technology through a modified 
Hummers method from NG as previously described.19 The 
nanopowders were dispersed in ultrapure water to prepare a 
1.0 mg/mL solution. Immediately prior to exposure to cells, 
hydrocolloids of nanoparticles were sonicated for 30 min 
and diluted to different concentrations with supplemented 
Dulbecco’s Modified Eagle’s culture Medium (DMEM, 
Thermo Fisher Scientific, Waltham, MA, USA).
Transmission electron microscopy (TEM) images of 
nanoparticles were acquired with a JEM-1220 microscope 
(JEOL, Tokyo, Japan) at 80 kV, with a Morada 11 megapixel 
camera (Olympus Soft Imaging Solutions, Münster, 
Germany) (Figure S1). Samples were prepared by placing 
droplets of hydrocolloids onto formvar-coated copper grids 
(Agar Scientific Ltd, Stansted, UK) and air dried before 
observations.
Zeta potential measurements were carried out with 
Nano-ZS90 Zetasizer (Malvern Instruments, Malvern, UK) 
at 25°C, using the Smoluchowski approximation. Each 
sample was measured after 120 s of stabilization at 25°C 
(20 replicates). Hydrodynamic diameter of nanoparticles in 
water was measured with dynamic light scattering (DLS) 
using a Nano-ZS90 Zetasizer (Malvern).
Nanoparticles were examined by vibrational spectros-
copy. Raman scattering was studied at 2.33 eV (532 nm 
visible [VIS] laser) for the NG and nGO powders. The ND 
powder was analyzed at 4.66 eV (266 nm ultraviolet [UV] 
laser) due to the strong fluorescence of ND in the VIS spec-
trum. An argon laser was used as the source of the VIS laser, 
whereas a Crylas FQCW266-50 diode pumped continuous 
wave solid-state laser (Berlin, Germany) was used as the 
source of UV. The scattered light was dispersed by a Jasco 
NRS 5100 (Easton, PA, USA) spectrometer working in back-
scattering mode. During the measurements, the laser beams 
were focused onto 10 μm spots. Nanoparticles were placed 
on a silicon substrate. For NG and nGO, spectral resolutions 
were fixed at 8.4 cm−1 and 3.5 mW laser power. In the case of 
ND, the spectral resolution was fixed at 20 cm−1 and 5 mW 
laser power. Figure S2 shows the registered Raman spectra 
of ND, and Figure S3 presents the comparison of the NG 
and nGO Raman spectra.
U87 and U118 glioblastoma cell lines
Human glioblastoma U87 and U118 cell lines were obtained 
from the American Type Culture Collection (Manassas, 
USA) and maintained in DMEM (Thermo Fisher Scientific) 
supplemented with 10% fetal bovine serum (FBS, Thermo 
Fisher Scientific) and 1% penicillin/streptomycin (Thermo 
Fisher Scientific) at 37°C in a humidified atmosphere of 5% 
CO
2
/95% air in an NuAire DH AutoFlow CO
2
 Air-Jacketed 
Incubator (Plymouth, MA, USA).
cell morphology
Scanning electron microscopy (SEM) observations of the 
U87 or U118 glioblastoma cells were done using a Quanta 
200 microscope (FEI, Hillsboro, OR, USA). U87 or U118 
glioblastoma cells were seeded in 35 mm diameter Petri 
dishes (1×105 cells per well). After 24 h, ND, NG, or nGO 
were introduced to the cells at a concentration of 20 μg/mL. 
Preparation of the cells for SEM observation was done after 
24 h of exposure to nanoparticles in accordance with the 
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protocol of Heckman et al.20 Cells were fixed with 2.5% 
glutaraldehyde in phosphate-buffered saline (PBS) 7.2 pH, 
contrasted with 1% osmium tetroxide (Sigma-Aldrich 
Co., St Louis, MO, USA) and 1% carbohydrazide (Sigma-
Aldrich). Subsequently, cells were dehydrated in increasing 
concentrations of hexylene glycol (Sigma-Aldrich). Drying 
was performed using a Polaron CPD 7501 critical point dryer 
(Quorum Technologies, Laughton, UK).
TEM analysis
Glioblastoma cell ultrastructure was assessed by TEM using 
a JEM-1220 microscope (JEOL) at 80 kV, with a Morada 
11 megapixel camera (Olympus Soft Imaging Solutions). 
U87 or U118 glioblastoma cells were seeded in 75 cm2 cell 
culture flasks (BD Biosciences, San Jose, CA, USA). After 
24 h, ND, NG, or nGO were introduced to cells at a concen-
tration of 20 μg/mL. After 24 h of incubation, the cells were 
trypsinized, washed with PBS (Sigma-Aldrich), centrifuged 
for 5 min at 1,200 rpm, and fixed in a 2.5% solution of glutar-
aldehyde in PBS 7.2 pH (Sigma-Aldrich). Pellets were 
contrasted in 1% osmium tetroxide (Sigma-Aldrich) and 
dehydrated in increasing concentrations of ethanol (Sigma-
Aldrich). Subsequently, pellets were impregnated with epoxy 
embedding resin (Epoxy Embedding Kit, Sigma-Aldrich). 
The next day, samples were embedded in the same resin and 
hardened for 24 h at 36°C and incubated at 60°C for another 
24 h. The blocks were cut into ultrathin sections (50–80 nm) 
using an ultramicrotome (LKB Ultratome III, Croydon, UK) 
and transferred onto copper grids, 200 meshes (Agar Scientific 
Ltd). Subsequently, the sections were contrasted using uranyl 
acetate (Sigma-Aldrich) and lead citrate (Sigma-Aldrich).
cell viability using the XTT assay
Cell viability was evaluated using an XTT-based cell prolif-
eration assay kit (Sigma-Aldrich). U87 and U118 cells were 
plated in 96-well plates (5×103 cells per well) and incubated 
for 24 h. Then, new medium containing ND, NG, or nGO 
was introduced to the cells at concentrations of 5, 20, 50, 
100, and 200 μg/mL. XTT solution was added to each well 
and incubated for an additional 3 h at 37°C. The absorbance 
of each well was recorded at 450 nm using a Tecan Infinite 
200 microplate reader (Tecan, Durham, USA). Cell viability 
after nanoparticle treatment was expressed as the percentage 
compared to the absorbance of control samples.
Migration assay
The migration of U87 and U118 cells was assessed using 
the cell exclusion zone assay. Cells were cultured in six-well 
plates with a rectangular silicone attachment (Sarstedt, 
Nümbrecht, Germany) (1×105 cells per well). After cells 
reached confluence, new medium containing ND, NG, or 
nGO at a concentration of 50 μg/mL was introduced to the 
cells. After 1 h of incubation, the silicone attachment was 
removed, and cells initiated migration. Images were taken 
immediately after silicone attachment removal (0 h time 
point) and after 48 h. Cell migration was analyzed after 
48 h with an inverted microscope (Olympus Soft Imaging 
Solutions). The area of migration was calculated using ImageJ 
1.48.21 All experiments were repeated at least three times.
Invasion assay
The invasiveness of U87 and U118 cells was determined by 
counting the number of cells that invaded through collagen-
coated (Sigma-Aldrich) Transwell inserts (BD Biosciences). 
Cells were trypsinized, washed twice, and suspended in 
serum-free medium. 5×104 cells were seeded in the Transwell 
inserts. After cells adhered to the Transwell insert, medium 
containing ND, NG, or nGO at a concentration of 50 μg/mL 
was introduced to the cells. Medium with 10% FBS (Thermo 
Fisher Scientific) was added to the lower chamber as a 
chemoattractant. Cells that passed through the filters into 
the lower part of Transwell inserts were fixed with 4% 
paraformaldehyde (Sigma-Aldrich). Cell nuclei were stained 
with 4′,6-diamidino-2-phenylindole (DAPI; Thermo Fisher 
Scientific) and counted in 10 fields of view under 100× 
magnification with an inverted confocal microscope FV-1000 
(Olympus Soft Imaging Solutions). The experiments were 
repeated at least three times.
adhesion assay
The adhesion of U87 and U118 cells in time points was 
determined using fluorescent microplate test. 96-well plates 
were coated with Geltrex Matrix (Thermo Fisher Scientific). 
Each well was coated with 100 μL Geltrex Matrix diluted to 
a final concentration of 1 mg/mL in DMEM without FBS. 
Plates were incubated for 1 h in 37°C, and Geltrex Matrix 
solution was aspirated and plates were air-dried. U87 and 
U118 cells were labeled using fluorescent kit – CytoPainter 
Cell Tracking Staining Kit – Green Fluorescence (Abcam). 
Before addition to wells, cells were treated with ND, NG, 
or nGO at a final concentration of 20 μg/mL in DMEM 
with 10% FBS for 30 min. After incubation 1.5×104 cells 
were added per well and after 15, 30, 60, and 120 min wells 
were gently washed three times with PBS. The intensity of 
fluorescence was read at excitation/emission =490/520 nm 
on a Tecan Infinite 200 microplate reader. Experiments were 
repeated two times.
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sample preparation for protein analysis
ND, NG, or nGO were introduced to cells at a concentration 
of 20 μg/mL and incubated for 24 h. Cells not treated with 
nanoparticles were used as the control. Cells were washed 
twice with PBS and harvested by centrifugation (200× g for 
6 min at 4°C). Whole-cell protein extracts were prepared 
by suspending cells in ice-cold radioimmunoprecipitation 
assay (RIPA) buffer with protease and phosphatase inhibitors 
(Sigma-Aldrich). The cells were incubated for 40 min on ice 
with vortexing at 10 min intervals followed by centrifugation 
for 30 min at 14,000× g at 4°C and collection of supernatant. 
Cytoplasmic and nuclear fractions were obtained by sus-
pending cells in hypotonic buffer (20 mM Tris-HCl, pH 7.4; 
10 mM NaCl; 3 mM MgCl
2
), followed by addition of Igepal 
CA-630 (Sigma-Aldrich) to a final concentration of 0.5% 
with protease and phosphatase inhibitors (Sigma-Aldrich) 
and vortexing for 10 s. Supernatant of homogenate (cytoplas-
mic fraction) was collected after centrifugation for 10 min at 
3,000 rpm at 4°C. Pellet (nuclear fraction) was resuspended 
in ice-cold RIPA buffer with protease and phosphatase 
inhibitors, incubated 30 min on ice with vortexing at 10 min 
intervals. Supernatant of homogenate (nuclear fraction) was 
collected after centrifugation for 30 min at 14,000× g at 4°C. 
Protein concentration was determined by the Bicinchoninic 
Acid Kit (Sigma-Aldrich).
enzyme-linked immunosorbent assay 
(elIsa) analysis
Levels of mTOR (pSer2448) and AKT (pS473) phosphoryla-
tion were assayed by ELISA using ab176657 and ab168538 
kits (Abcam, Cambridge, UK). The results were normalized 
to the total protein content determined by the Bicinchoninic 
Acid Kit (Sigma-Aldrich). Protein concentrations were 
measured in accordance with the manufacturer’s instruc-
tions using lysates containing 100 μg/mL of total protein. 
A standard curve was made for each assay using serial dilu-
tions of the control lysates. All experiments were repeated 
twice, using cell extracts from three separate experiments.
Western blot analysis
An equal volume of samples was denatured with sample 
buffer containing beta-mercaptoethanol (Bio-Rad) and 5 min 
boiling. Proteins were resolved under reductive conditions 
with sodium dodecyl sulfate polyacrylamide gel electropho-
resis and transferred to nitrocellulose membranes using the 
Trans-Blot Turbo Transfer System (Bio-Rad). Membranes 
were blocked with 5% non-fat milk (Bio-Rad) in PBS for 
60 min. Membranes were then incubated with primary 
antibodies in PBS with 5% non-fat milk or for detection of 
phosphorylated proteins with 1% BSA (Sigma-Aldrich) at 
4°C overnight.
The following primary antibodies were used: vinculin 
monoclonal antibody, Thermo Fisher Scientific, 700062; 
N-cadherin monoclonal antibody, Thermo Fisher Scientific, 
MA1-159; pan-cadherin polyclonal antibody, Thermo 
Fisher Scientific, 71-7100; beta catenin polyclonal antibody, 
Thermo Fisher Scientific, PA5-19469; EGFR polyclonal anti-
body, Thermo Fisher Scientific, PA1-1110; phospho-EGFR 
monoclonal antibody pTyr1173, Thermo Fisher Scientific, 
MA5-15158; glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) monoclonal antibody, Thermo Fisher Scientific, 
MA5-15738; β-tubulin monoclonal antibody, Santa Cruz 
Biotechnology Inc., Dallas, TX, USA, Sc-5274. Proliferating 
cell nuclear antigen (PCNA) monoclonal antibody, Thermo 
Fisher Scientific, 13-3900. The secondary antibody (goat 
anti-mouse WesternDot 625 or goat anti-rabbit WesternDot 
625) diluted 1:500 was incubated with the membrane in 
PBS with 5% non-fat dry milk for 1 h at room tempera-
ture. GAPDH was used as a loading control for whole-cell 
lysate, whereas β-tubulin and PCNA were used as a loading 
control for cytoplasmic and nuclear fractions, respectively. 
Membranes were visualized using a GelDoc imaging system 
(Bio-Rad). Quantification and background correction were 
carried out using ImageJ 1.48.21
cytoskeleton analysis
Cells were grown on glass bottom 35 mm2 dishes coated with 
Geltrex Matrix (Thermo Fisher Scientific). Each dish was 
coated with 500 μL Geltrex Matrix diluted to a final concen-
tration of 1 mg/mL in DMEM without FBS. Plates were incu-
bated for 1 h in 37°C and Geltrex Matrix solution was aspirated 
and dishes were air-dried (Nest Scientific, Rahway, NJ, USA). 
After 24 h of incubation, cells were treated with ND, NG, or 
nGO nanoparticles at the concentration of 20 μg/mL for the 
next 24 h. Subsequently, cells were washed twice with PBS 
and fixed with 4% paraformaldehyde (Sigma-Aldrich). Actin 
cytoskeleton was stained with phalloidin conjugated with Atto 
633 (Sigma-Aldrich). Imaging was performed using Olympus 
FV1000 confocal microscope (Olympus Soft Imaging Solu-
tions) equipped with 60× oil immersion objective.
statistical analysis
Data were analyzed using multifactorial analysis of variance 
with Statgraphics Centurion XVI (StatPoint Technologies, 
Warrenton, VA, USA). Differences between groups were tested 
with the Tukey’s honest significant difference post hoc test. 
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Results are shown as mean with standard deviation. Differences 
at P,0.05 were considered significant. Adhesion test data were 
analyzed using GraphPad Prism 5 (GraphPad Software Inc., 
La Jolla, CA, USA) with two-way analysis of variance and 
Bonferroni post hoc test comparing to the control at different 
time points. Results are shown as mean with standard deviation. 
Differences at P,0.05 were considered significant.
Results and discussion
Physicochemical characterization and 
toxicity of nanoparticles
TEM images (Figure S1) and Raman spectra of ND, NG, and 
nGO (Figures S2 and S3) are presented in the supplement. 
The registered Raman spectra were characteristic for these 
kinds of carbon materials.22 The spectra of NG and nGO 
consisted of two bands: a D band located at ~1,350 cm−1 and 
a G band at ~1,580 cm−1. The G band appears due to the C–C 
sp2 vibrations,23 while the D peak always indicates defects 
present in the carbon lattice.24,25 The very high intensity of 
the D/G band ratio of the presented spectra indicates that 
these were ultra-fine powders.26 The ND Raman spectrum 
consists of G and D bands as well as the so-called T band 
that is characteristic of sp3 binding around 1,100 cm−1 and a 
vibration characteristic for diamond around 1,330 cm−1.27,28 
TEM analyses were used to evaluate morphology of nanopar-
ticles (Table 1). Additionally, DLS analysis was performed to 
determine the average hydrodynamic diameter of nanopar-
ticles. The zeta potential was analyzed to characterize surface 
charges and the stability of the suspensions (Table 1).
To evaluate ND, NG, and nGO toxicity in U87 and U118 
glioblastoma cells, the viability of the cells was examined 
using the XTT assay (Figure 1). ND, NG, and nGO were 
added to cell cultures at concentrations of 10, 20, 50, 100, 
and 200 μg/mL. The reduction in cell viability was dose-
dependent and was strongest after NG treatment, followed by 
nGO and ND treatment. NG at a concentration of 200 μg/mL 
reduced the viability of the U87 cell line by 42% and that of 
the U188 cell line by 23%.
The results of viability assays were in accordance with 
the results from different studies, showing that the in vitro 
toxicity of graphene oxide is low.29,30 Graphene oxide, 
especially at low concentrations, does not show obvious 
cytotoxic effects on the human-derived cell lines A549 and 
SH-SY5Y.31,32 However, graphene oxide reduces glioblas-
toma cell viability and proliferation with increasing doses.12 
The toxicity of graphene oxide on mesenchymal stem cells 
depends on the size of the nanoparticles. nGO with a size 
of 11 nm induces a stronger reduction in proliferation and 
reactive oxygen species formation than larger particles.33 
Similarly, ND and NG show low toxicity on glioblastoma 
and hepatocellular carcinoma cells.34 Moreover, ND has been 
suggested to be biocompatible with neuroblastoma cells and 
macrophages.35 However, neuroblastoma cells lose their 
neurite extensions after incubation with ND at a concentra-
tion of 100 μg/mL, and macrophages show morphological 
changes at this dose.16
Nanoparticle association with the plasma 
membrane and uptake
SEM images showed that nanoparticles were present on 
the surface of the body of cells and protrusions (Figure 2). 
ND, NG, and nGO agglomerated on the plasma membrane 
surface. High magnification SEM images demonstrated that 
the glioblastoma surface after treatment with NG and to a 
Table 1 Physicochemical properties of diamond nanoparticles, 
graphite nanoparticles and graphene oxide nanoplatelets
Nanoparticle Zeta 
potential 
(mV)
Size of 
nanoparticle 
(TEM, nm)
Average 
hydrodynamic 
diameter (DLS, nm)
Diamond 
nanoparticle
21.1 2–7 109.4
graphite 
nanoparticle
40.6 3–10 204.3
graphene oxide 
nanoplatelets
19.4 2–8 126.2
Abbreviations: TeM, transmission electron microscope; Dls, dynamic light 
scattering.
Figure 1 U87 and U118 glioblastoma cell viability.
Notes: cell viability was determined using the XTT assay. cells were exposed 
to diamond nanoparticles (ND), graphite nanoparticles (Ng), and graphene oxide 
(ngO) at concentrations of 10, 20, 50, 100, and 200 μg/ml for 24 h. Values are 
expressed as mean ± standard deviation (n=4, each experiment in duplicate). 
Statistical significance between control (C) and the treated cells is indicated by an 
asterisk (multifactor analysis of variance [aNOVa]; P,0.05). There was statistical 
significance between U87 and U118 viability (P=0.0000) and the interaction between 
cell line and the type of nanoparticle (P=0.0000).
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greater extent nGO showed irregularities, visible as less 
electron-dense spots, suggesting direct interactions of nGO 
with plasma membranes.
To determine whether the examined nanoparticles entered 
glioblastoma cells, further microscopic studies were per-
formed. Nanoparticle uptake and cellular localization were 
assessed using TEM (Figure 3). U87 and U118 cells were 
treated with nanoparticles at a concentration of 20 μg/mL 
and incubated for 24 h. The examination of glioblastoma 
cell ultrastructure revealed that ND, NG, and nGO were 
located inside cells. However, the amount of ND and NG 
inside cells was approximately three times greater than that 
of nGO. Nanoparticles were localized inside vacuoles and in 
the cytoplasm. nGO more often than ND and NG were found 
to damage vacuoles and reach the cytoplasm.
The investigation of endocytosis and the morphology 
of glioblastoma cells suggests different behavior of the 
examined carbon nanoparticles, especially for ND and nGO. 
ND were effectively taken up by the cells, whereas nGO 
strongly interacted with the cell surface. Interestingly, NG 
showed features of both ND and nGO, which may be related 
to the sp2 atom hybridization similar to nGO and the spherical 
structure similar to ND. Many vacuoles were loaded with 
nanoparticles, especially after treatment with ND and NG, 
suggesting that endocytosis of these nanoparticles is prefer-
ential and profound.
Figure 2 scanning electron microscopy of U87 and U118 glioblastoma cells.
Notes: electron microscopic images were taken after treatment with nanoparticles at 20 μg/ml for 24 h. arrows on the scanning electron microscope images indicate 
agglomerates of nanoparticles, and arrowheads indicate cell surface irregularities. scanning electron microscope images of U87 and U118 cells without treatment (c) and 
after treatment with diamond nanoparticles (ND), graphite nanoparticles (Ng), and graphene oxide (ngO).
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Nanoparticles decrease adhesion and 
migration of glioblastoma cells
To examine whether nanoparticles, after attachment to the 
cell membrane and endocytosis, can mitigate the ability 
of glioblastoma cells to adhere to extracellular matrix and 
migrate, we performed an adhesion test, two-dimensional 
migration assay, and a three-dimensional invasion assay.
Adhesion test was performed in four time points (15, 30, 
60, and 120 min). Treatment with ND, NG, or nGO decreased 
adhesion of both glioma cell lines. U87 had decreased adhe-
sion starting from 30 min time point (Figure 4E), whereas 
U118 starting from 15-time point (Figure 4F).
Two-dimensional migration assay provides information 
about the abilities of cancer cells to move within a cell-free 
Figure 3 Ultrastructure of U87 and U118 glioblastoma cells.
Notes: electron microscopic images were taken after treatment with nanoparticles at 20 μg/ml for 24 h. Transmission electron microscope images of U87 and U118 cells 
without treatment (c) and after treatment with diamond nanoparticles (ND), graphite nanoparticles (Ng), and graphene oxide (ngO). arrows indicate nanoparticles. scale 
bar 1 μm.
Abbreviations: aP, autophagosome; eV, endocytic vesicle; Mi, mitochondrion; MVB, multivesicular body; N, nucleus; PMF, plasma membrane fold.
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area and is done without scratching off cells, which can 
influence the results due to the release of growth factors 
from damaged cells.36 Treatment with ND, NG, or nGO at 
a concentration of 50 μg/mL reduced the two-dimensional 
migration of both U87 and U118 glioblastoma cells by 
approximately twofold (Figure 4). The strongest inhibition 
was observed after treatment with ND. U87 cells showed a 
stronger ability to migrate than U188. Although both U87 
and U118 cell lines are able to migrate and are tumorigenic 
in animal models, U87 is approximately eight times more 
Figure 4 U87 and U118 glioblastoma cell motility and adhesion.
Notes: Migration of glioblastoma cells was determined using the cell exclusion zone assay. cells were treated with nanoparticles at 50 μg/ml. (A) U87 and U118 glioblastoma 
cells before treatment (0 h time point) and after 48 h not treated with nanoparticles and treated with diamond nanoparticles, graphite nanoparticles, and graphene oxide 
nanoparticles. (B) The invasiveness of U87 and U118 cells was determined by staining the nuclei of cells that had invaded through collagen-coated Transwell inserts with 
DaPI. Nuclei were counted using a confocal microscope after treatment with nanoparticles at 50 μg/ml. (C) graph shows the percentage of the zone covered by cells. 
Values are expressed as mean ± standard deviation (n=3, each experiment in triplicate). Statistical significance is indicated with different superscripts (multifactor ANOVA; 
P,0.05). There was a significant difference between U87 and U118 migration (P=0.0000). No interactions between cell line and the type of nanoparticle were observed 
(P=0.0623). (D) graph shows the percentage of cell invasion compared to control. Values are expressed as mean ± standard deviation (n=3, each experiment in triplicate). 
Statistical significance is indicated with different superscripts (multifactor ANOVA; P,0.05). There was no statistical significance between U87 and U118 invasion (P=0.3034); 
however, an interaction between cell line and the type of nanoparticle was observed (P=0.0003). (E, F) Adhesion of fluorescent-labeled U87 and U118 cells after treatment 
with nanoparticles at 20 μg/ml. 96-well plates were coated with extracellular matrix. after 15, 30, 60, and 120 min wells were gently washed three times and intensity of 
fluorescence was read at microplate reader. Values are expressed as mean ± standard deviation (n=3, each experiment in triplicate). Statistical significance between control 
and experimental groups is indicated with superscripts (multifactor aNOVa, *P,0.05; ***P,0.001).
Abbreviations: aNOVa, analysis of variance; c, control; DaPI, 4′,6-diamidino-2-phenylindole; ND, diamond nanoparticles; Ng, graphite nanoparticles; ngO, graphene 
oxide nanoparticles.
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invasive than U118 cells.37 Moreover, U87 cells can form 
approximately twofold larger tumors than U118 cells after 
the same duration of tumor development in immunodeficient 
mice.38 Similar observations were made when U87 and U118 
cells were inoculated into the chorioallantoic membrane of 
chicken embryos.39
The three-dimensional invasion assay was used to evaluate 
whether tumor cells can pass through collagen-coated pores 
into medium containing a chemoattractant. In both cell lines, 
the invasion abilities were significantly reduced after treatment 
with ND, NG, or nGO at a concentration of 50 μg/mL (Figure 
4). The strongest inhibition was observed after treatment with 
nGO and NG, whereas ND reduced invasion to a lesser extent. 
There were no significant differences between the invasive-
ness of the U87 and U118 glioblastoma cell lines. However, 
we observed an interaction between the type of cell and the 
type of nanoparticle. In both models, nanoparticles reduced 
the migration capabilities of glioblastoma cells.
The invasion model is more similar to in vivo conditions 
than the two-dimensional migration model because cells 
need to interact with the extracellular matrix and respond to 
a chemoattractant and thus require different cell signaling 
pathways.40 Cells migrating in the two-dimensional models 
often display only sparse filopodia, whereas in the three-
dimensional invasion model or in vivo, cells extensively use 
filopodia to probe the extracellular matrix and migrate.41,42 
Both cell lines exhibited mutations in PTEN, whereas U118 
also revealed p53 mutation. Glioblastoma cell lines with 
mutations in PTEN and both PTEN and p53 show increased 
membrane folding, however, cell lines containing both muta-
tions have largest surface areas.3 U118 after treatment with 
NG showed approximately twofold higher reduction of cell 
invasion than U87 cells. There was no difference between 
cell lines after treatment with nGO, which could be related 
to a lower level of endocytosis.
To better understand interaction of cells with extracellular 
matrix cytoskeleton was analyzed. Images of actin cytoskeleton 
(Figure 5A) show that treatment with nanoparticles led to 
actin remodeling in cells, decreasing amount of stress fibers in 
cytoplasm. Moreover, cells treated with nanoparticles showed 
intensive F-actin formation in cell cortex, suggesting need of 
stabilization of cell adhesion. Cortical actin stabilizes integrin 
and cadherin adhesions and regulates intercellular tension.43,44 
Stress fibers in cytoplasm stabilize cell and generate traction 
force during migration and are ended with focal adhesion 
complexes.6 ND, NG, and nGO nanoparticles decreased 
adhesion of cells to extracellular matrix showing similar 
effect to extracellular matrix with low mechanical rigidity. 
Glioblastoma cells with low mechanical rigidity surface alter 
cell motility and cytoskeletal architecture.45
Nanoparticles decrease adhesion-
dependent signaling pathways
To determine if changes in migration are associated with 
protein expression of adhesion molecules, levels of vinculin 
and cadherin proteins were examined (Figure 5B). Treatment 
with nanoparticles did not alter protein levels of vinculin, 
N-cadherin, and pan-cadherin. This suggests that nanopar-
ticles change cell migration by impeding connection between 
cells and extracellular matrix.
EGFR/AKT/mTOR signaling pathway was analyzed by 
assessment of phosphorylation levels of EGFR, AKT, and 
mTOR protein. Treatment with ND, NG, and especially with 
nGO decreased level of phospho-EGFR (pTyr1173), whereas 
did not alter total level of EGFR protein (Figure 5B). The 
nanoparticles also decreased the activation of two down-
stream targets of EGFR, AKT, and mTOR (Figure 5D). 
Cell adhesion with extracellular matrix leads to ligand-
independent activation of EGFR.46,47 Integrins induce phos-
phorylation of EGF receptor on tyrosine residues 845, 1068, 
1086, and 1173, but not on residue 1148, a major site of 
phosphorylation in response to EGF.48 Treatment with ND, 
NG, and nGO decreased level of phosphor-EGFR (pTyr1173) 
probably by decreasing glioblastoma cells’ adhesion.
β-Catenin signaling was analyzed by assessment of level 
of β-catenin in nuclear and cytoplasmic fractions using 
Western blot method (Figure 5C). NG and nGO nanopar-
ticles caused decrease in β-catenin level in nuclear fraction. 
ND affected β-catenin activity only after treatment of U87 
cell line. β-Catenin is important protein in cadherin-based 
adhesions and is also an essential coactivator of canonical 
Wnt-mediated gene expression. Canonical Wnt signaling and 
cadherin-mediated cell adhesion depend on the same pool 
of β-catenin.49 Decrease in nuclear level of β-catenin without 
changes in cadherin protein level suggests that treatment with 
nanoparticles leads to stabilization of β-catenin pool connected 
with cadherin junctions. The affinity between cadherin 
and β-catenin at junctions is increased by inhibition of 
receptor tyrosine kinases including EGFR.50–52 NG and nGO 
that inhibit EGFR phosphorylation to higher extent than ND 
caused also a decrease in nuclear level of β-catenin.
Downstream of EGFR, AKT, and mTOR plays important 
roles in many cellular processes, including proliferation, 
apoptosis, cell cycle progression, cell motility, and autophagy. 
The pathway is constantly activated in glioblastoma and 
other tumors, including breast cancer, gastric cancer, and 
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hepatocellular carcinoma.53 PI3K activates AKT by phospho-
rylation, which changes its localization to the nucleus where 
it activates mTOR and downstream targets. mTOR functions 
as two distinct complexes, mTORC1 and mTORC2. The 
suppression of mTORC1 leads to stimulation of mTORC2, 
which positively regulates cell survival and proliferation at 
different signaling levels, mainly by the activation of AKT.54 
Apart from inhibition of EGFR phosphorylation, a decrease 
in the activation of mTOR could be caused by profound 
endocytosis of nanoparticles. Reports have shown that 
mTORC1 activation can be decreased during the failure of 
lysosome reformation.55–57 Lysosome reformation occurs in 
endolysosomes or autolysosomes after processing a substrate. 
Inefficient digestion of substrates can lead to the accumulation of 
endolysosomes in the cytosol,55,58 thereby decreasing lysosome 
reformation and mTORC1 activation. Thus, intensive endocy-
tosis of nanoparticles, which are indigestible by cells, can lead 
to a decrease in mTORC1 activation and nutrient starvation.
Additionally, endocytosis of nanoparticles could lead to the 
internalization of large areas of the plasma membrane, thus 
decreasing the availability of receptor tyrosine kinases that, after 
binding with their ligands, activate the AKT/mTOR signaling 
pathway.59 Macropinocytosis is a possible way of entering into 
the cell for nanoparticles with size ,10 nm, thereby delivering 
Figure 5 egFr/aKT/mTOr and β-catenin signaling in glioblastoma cells after treated with nanoparticles. 
Notes: (A) confocal microscope images of U87 and U118 cells actin cytoskeleton. cells were grown on extracellular matrix for 24 h and treated with diamond nanoparticles, 
graphite nanoparticles, or graphene oxide nanoparticles at a concentration of 20 μg/ml and incubated for 24 h. F-actin was stained with phalloidin conjugated with atto 633. 
(B) Western blot analysis of N-cadherin, pan-cadherin, vinculin, p-egFr, and egFr. gaPDh was used as a loading control. (C) Western blot analysis of nuclear and 
cytoplasmic protein fractions used for determination of β-catenin protein level. PcNa and β-tubulin were used as loading controls for nuclear and cytoplasmic fractions, 
respectively. (D) ELISA analysis of AKT and mTOR phosphorylation in comparison to control. Treatment with nanoparticles significantly reduced phospho-AKT (P,0.0000) 
and mTOr (P,0.0000). Phospho-aKT level was cell line dependent (P,0.0000) and was affected by interaction of cell line and nanoparticles (P,0.001). Phospho-mTOr 
level was also cell line dependent (P,0.0023) and was affected by interaction of cell line and nanoparticles (P,0.0000). Values are expressed as mean ± standard deviation 
(n=5, each experiment in duplicate). Statistical significance is indicated with different superscripts (multifactor ANOVA; P,0.05).
Abbreviations: aNOVa, analysis of variance; c, control; elIsa, enzyme-linked immunosorbent assay; gaPDh, glyceraldehyde 3-phosphate dehydrogenase; ND, diamond 
nanoparticles; Ng, graphite nanoparticles; ngO, graphene oxide nanoparticles.
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nanoparticles to early endosomes, late endosomes, and subse-
quently to lysosomes.60 However, agglomerates of ND, NG, 
and nGO could be effectively internalized by endocytosis.61,62 
Ligand-unmodified polymeric nanoparticles have been shown 
to enter U87 cells by mainly clathrin-dependent endocytosis 
and macropinocytosis.63 Ligand-unmodified iron oxide nano-
particles and silica-coated iron oxide nanoparticles also enter 
HeLa cells (human cervical cancer) by endocytosis, but mainly 
in a caveolin-dependent way.64 This suggests that nanoparticle 
uptake is conducted by endocytosis, which depends on the size 
and surface characteristics of the nanoparticles.65 Non-spherical 
nanoparticles have a higher area of interaction with the plasma 
membrane. nGO examined in this study probably strongly 
interacted with the plasma membrane, leading to changes in 
cell surface morphology and caused strongest decreases in 
EGFR phosphorylation. Further investigations are required to 
explore the biological mechanisms of the interaction between 
the EGFR/AKT/mTOR signaling pathway and endocytosis 
triggered by ND, NG, and nGO nanoparticles.
We have demonstrated that ND, NG, and nGO nanopar-
ticles caused decrease in U87 and U118 adhesion that led to 
decrease in migration and invasiveness of the glioblastoma 
cell lines U87 and U118 affecting activity of EGFR/AKT/
mTOR and β-catenin signaling pathways. These results 
indicate that the examined nanoparticles could be used as 
a low toxicity glioblastoma therapy, especially as an active 
compound for drug delivery.
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Figure S1 Transmission electron microscopic images of nanoparticles.
Note: Images of diamond nanoparticles (A), graphite nanoparticles (B), and graphene oxide (C).
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Figure S2 raman spectra of diamond nanoparticles. 
Note: spectra consist of the vibration characteristic for diamond at ~1,330 cm−1 and three bands: a T band located at ~1,100 cm−1, a D band at ~1,290 cm−1, and a g band 
at ~1,640 cm−1.
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Figure S3 raman spectra of graphite nanoparticles and graphene oxide.
Notes: spectra consist of two bands: a D band located at ~1,350 cm−1 and a g band at ~1,580 cm−1. raman spectra of graphite nanoparticles and graphene oxide were 
normalized to the g band peak.
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